ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
Hemogenyx Pharmaceuticals Plc

Hemogenyx Pharmaceuticals Plc (HEMO)

350,00
-28,00
(-7,41%)
Fermé 18 Décembre 5:30PM

Outils de qualité professionnelle, pour des investisseurs individuels.

Statistiques et détails clés

Dernier
350,00
Prix Achat
335,00
Prix Vente
355,00
Volume échangé
137 706
275,00 Fourchette du Jour 380,00
275,00 Plage de 52 semaines 2 520,00
Cap du marché
Clôture Veille
378,00
Ouverture
380,00
Dernière Transaction
187
@
350
(UT)
Dernière heure de transaction
Volume financier
442 341p
VWAP
321,2215
Volume moyen (3 m)
15 083 665
Actions en circulation
3 504 539
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-1,86
Bénéfice par action (BPA)
-1,91
Chiffre d'affairess
-
Bénéfice net
-6,69M

À propos de Hemogenyx Pharmaceuticals Plc

Secteur
Finance Services
Industrie
Finance Services
Site Web
Siège social
London, Gbr
Fondé
-
Hemogenyx Pharmaceuticals Plc est coté dans le secteur Finance Services de la London Stock Exchange avec le ticker HEMO. Le dernier cours de clôture d'Hemogenyx Pharmaceuticals était de 378,00p. Au cours de la dernière année, les actions de Hemogenyx Pharmaceuticals ont été négociées dans une fourchette de prix de 275,00p à 2 520,00p.

Hemogenyx Pharmaceuticals compte actuellement 3 504 539 actions en circulation. La capitalisation boursière d'Hemogenyx Pharmaceuticals est de £13,25 million. Hemogenyx Pharmaceuticals a un ratio cours/bénéfice (ratio PE) de -1.86.

HEMO Dernières nouvelles

Hemogenyx Pharmaceuticals PLC Admission of New Ordinary Shares and New ISIN

Hemogenyx Pharmaceuticals PLC 10 December 2024   10 December 2024   Hemogenyx Pharmaceuticals plc  ("Hemogenyx Pharmaceuticals" or the "Company")   Admission of New Ordinary Shares and New...

Hemogenyx Pharmaceuticals PLC Result of Extraordinary General Meeting

Hemogenyx Pharmaceuticals PLC 09 December 2024   9 December 2024   Hemogenyx Pharmaceuticals plc  ("Hemogenyx Pharmaceuticals" or the "Company") Result of Extraordinary General Meeting  ...

Hemogenyx Pharmaceuticals PLC Site Initiation Visit Completed

Hemogenyx Pharmaceuticals PLC 09 December 2024   9 December 2024   Hemogenyx Pharmaceuticals plc  ("Hemogenyx Pharmaceuticals" or the "Company")   Site Initiation Visit Completed   Hemogenyx...

TRADING UPDATES: SDX plots AIM exit; Celadon receives funds

The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Al ...

Hemogenyx Pharmaceuticals PLC CBR Macrophage Delivery Update

Hemogenyx Pharmaceuticals PLC 06 December 2024   6 December 2024   Hemogenyx Pharmaceuticals plc  ("Hemogenyx Pharmaceuticals" or the "Company")   CBR Macrophage Delivery   Breakthrough in...

Hemogenyx Pharmaceuticals PLC Total Voting Rights

Hemogenyx Pharmaceuticals PLC 29 November 2024   29 November 2024   Hemogenyx Pharmaceuticals plc  ("Hemogenyx Pharmaceuticals" or the "Company")   Total Voting Rights   Hemogenyx...

Hemogenyx Pharmaceuticals PLC Notice of Extraordinary General Meeting

Hemogenyx Pharmaceuticals PLC 22 November 2024   22 November 2024   Hemogenyx Pharmaceuticals plc ("Hemogenyx Pharmaceuticals" or the "Company")   Notice of Extraordinary General Meeting...

Hemogenyx Pharmaceuticals PLC IRB Approval for Phase I Clinical Trial

Hemogenyx Pharmaceuticals PLC 22 November 2024   22 November 2024   Hemogenyx Pharmaceuticals plc  ("Hemogenyx Pharmaceuticals" or the "Company")   IRB Approval for Phase I Clinical Trial  ...

Hemogenyx Pharmaceuticals PLC Institutional Investment

Hemogenyx Pharmaceuticals PLC 11 November 2024   11 November 2024   Hemogenyx Pharmaceuticals plc ("Hemogenyx Pharmaceuticals" or the "Company")   Institutional Investment of £600,000...

IN BRIEF: Hemogenyx to launch myeloid leukemia treatment phase 1 trial

euticals PLC - London-based biopharmaceutical company focused on treatments for blood diseases - Schedules the opening ...

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1-70.8-16.825095057420.84302753859100413.73679929DE
4-150.8-30.1118210863500.872027520240300466.19711769DE
12-269.2-43.4754521964619.280027515083665507.32811237DE
26-230.8-39.738292011580.88002759565017517.78403492DE
52-570-61.9565217391920252027510005939733.76513076DE
156-270-43.548387096862025202757978241764.20933153DE
260-410-53.9473684211760615027596682731257.46027839DE

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
TM1Technology Minerals Plc
0,265p
(140,91%)
635,73M
HUMHummingbird Resources Plc
2,30p
(39,39%)
8,51M
QEDQuadrise Plc
6,00p
(29,03%)
28,48M
LPALpa Group Plc
72,00p
(26,32%)
63,26k
DARDar Global Plc
US$ 6,00
(22,45%)
16,75k
APIAbrdn Property Income Trust Limited
9,51p
(-84,36%)
13,57M
KDNCCadence Minerals Plc
1,65p
(-40,00%)
17,87M
BLUBlue Star Capital Plc
0,015p
(-25,00%)
18,2M
SYMESupply@me Capital Plc
0,0034p
(-22,73%)
1,43B
SCGLSealand Capital Galaxy Limited
1,40p
(-22,22%)
6,15M
NTVONativo Resources Plc
0,0021p
(-12,50%)
4,78B
SYMESupply@me Capital Plc
0,0034p
(-22,73%)
1,43B
TRPTower Resources Plc
0,031p
(8,77%)
637,54M
TM1Technology Minerals Plc
0,265p
(140,91%)
635,73M
ORCPOracle Power Plc
0,026p
(-3,70%)
340,06M
Aucune Discussion Trouvée
Ajouter une Discussion